Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications

Alpha 1 antitrypsin deficiency is a hereditary condition characterized by low alpha 1 proteinase inhibitor (also known as alpha 1 antitrypsin [AAT]) serum levels. Reduced levels of AAT allow abnormal degradation of lung tissue, which may ultimately lead to the development of early-onset emphysema. I...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Chron Obstruct Pulmon Dis
Egile Nagusiak: Chapman, Kenneth R, Chorostowska-Wynimko, Joanna, Koczulla, A Rembert, Ferrarotti, Ilaria, McElvaney, Noel G
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2018
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5797472/
https://ncbi.nlm.nih.gov/pubmed/29430176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S149429
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak